The U.S. Patent and Trademark Office ruled that the use of CRISPR-Cas9 in humans belongs to the Broad Institute of Massachusetts Institute of Technology, not the University of California, Berkeley.

Biotech company Psycheceutical Inc. of Ft. Lauderdale, Fla., was issued two patents by the United States Patent and Trademark Office for what it calls a “precision duplicity” approach to delivering psychedelic drugs to patients.

A U.S. patent review board on Monday declined to review petitions brought by hedge-fund manager Kyle Bass, who has sought to employ an unusual trading strategy of challenging patents held […]